Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India

Tropical Medicine and International Health

Volumn 18, Issue 9, 2013, Pages 1141-1144

  Ramachandran, Geetha ^a   Chandrasekaran, Vedachalam ^a   Hemanth Kumar, Agibothu Kupparam ^a   Dewan, Puneet ^b   Swaminathan, Soumya ^a   Thomas, Aleyamma ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Anti TB drugs; Drug content; Revised National TB Control Programme

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

DISEASE TREATMENT; DRUG; ESTIMATION METHOD; GEOGRAPHICAL REGION; HEALTH CARE; HEALTH SERVICES; SPECTROPHOTOMETRY; TUBERCULOSIS;

ARTICLE; DRUG MANUFACTURE; HEALTH CARE FACILITY; HEALTH PROGRAM; HOSPITAL PURCHASING; HUMAN; INDIA; TUBERCULOSIS CONTROL;

ANTI-TB DRUGS; DRUG CONTENT; REVISED NATIONAL TB CONTROL PROGRAMME;

ANTITUBERCULAR AGENTS; CYCLOSERINE; DRUG STABILITY; DRUG STORAGE; DRUG THERAPY, COMBINATION; ETHAMBUTOL; ETHIONAMIDE; HUMANS; INDIA; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPIN; SPECTROPHOTOMETRY; TUBERCULOSIS;

INDIA; TAMIL NADU;

EID: 84881656724     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12158     Document Type: Article

References (16)

1. Ashokraj Y, Agrawal S, Varma MVS et al. (2004) Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study. The International Journal of Tuberculosis and Lung Disease 8, 1081-1088.
2. Bate R, Tren R, Mooney L et al. (2009) Pilot study of essential drug quality in two major cities in India. PLoS ONE 4, e6003.
3. Bate R, Jensen P, Hess K, Mooney L & Milligan J (2013) Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. The International Journal of Tuberculosis and Lung Disease 17, 308-311.
4. Canetti G (2007) Host factors and chemotherapy of tuberculosis. In: Barry VC ed. Chemotherapy of tuberculosis, London, Butterworths, p 175. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. Journal of Antimicrobial Chemotherapy 60, 214-236.
5. Caudron JM, Ford N, Henkens M, Mace C, Kiddle-Monroe R & Pinel J (2008) Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Tropical Medicine & International Health 13, 1062-1072.
6. Ellard GA (1999) The colorimetric analysis of anti-tuberculosis fixed dose combination tablets and capsules. The International Journal of Tuberculosis and Lung Disease 3(Suppl 3), S343-S346.
7. Gurumurthy P, Narayana ASL, Raghupati Sarma G & Somasundaram PR (1984) Assay of ethambutol in pharmaceutical preparations. Lung India 2, 143-145.
8. International Medical Products Anti-Counterfeiting Taskforce Brochure (2008). Available at: www.who.int/impact/FinalBrochureWHA2008a.pdf, accessed on 14 Feb, 2013.
9. Jones LR (1956) Colorimetric determination of cycloserine: a new antibiotic. Analytical Chemistry 28, 39.
10. Kelesidis T, Kelesidis I, Refailidis PI & Falagas ME (2007) Counterfeit or substandard antimicrobial drugs: a review of scientific evidence. Journal of Antimicrobial Chemotherapy 60, 214-236.
11. Laserson KF, Kenyon AS, Kenyon TA, Layloff T & Binkin NJ (2001) Substandard tuberculosis drugs on the global market and their simple detection. The International Journal of Tuberculosis and Lung Disease 5, 448-454.
12. Mitchison DA (1993) Assessment of new sterilising drugs for treating pulmonary tuberculosis by culture at 2 months. The American Review of Respiratory Disease 147, 1062-1063.
13. Newton PN, Green MD, Fernandez FM, Day NP & White NJ (2006) Counterfeit anti-infective drugs. The Lancet Infectious Diseases 6, 602-613.
14. Rao KVN, Eidus L, Evans C et al. (1968) Deterioration of Cycloserine in the tropics. Bulletin of the World Health Organization 39, 781-789.
15. Rao KVN, Kailasam S, Menon NK & Radhakrishna S (1971) Inactivation of isoniazid in a syrup preparation. Bulletin of the World Health Organization 45, 625-632.
16. World Health Organisation report. Survey of the quality of anti-TB medicines circulating in the newly independent states of the former Soviet Union. 2011.